Zylö Therapeutics focuses on enhancing drug delivery through its innovative encapsulation technology, which aims to improve the efficacy and outcomes of therapeutic treatments. The company utilizes its proprietary Z-pods® system, designed to optimize the delivery of drugs, ensuring that they reach their intended targets more effectively. This advanced encapsulation method is intended to enhance the bioavailability of various compounds, potentially leading to better patient outcomes and more efficient treatment regimens.

The company’s pipeline includes a range of products that leverage this encapsulation technology, indicating a commitment to developing novel therapeutic solutions. By improving the delivery mechanisms of drugs, Zylö Therapeutics aims to address existing challenges in the pharmaceutical industry, such as poor solubility and inconsistent absorption rates. This focus on innovative drug delivery systems positions Zylö Therapeutics as a forward-thinking player in the biotechnology sector, with the potential to significantly impact patient care and treatment effectiveness.

United States

Zylö develops Z-pods® that are highly engineered amorphous silica particles designed to encapsulate compounds and improve product performance in a wide range of market segments.

Greenville, South Carolina, United States

Zylö Therapeutics

Company Details